ADRA2A anticorps (AA 385-450) (AbBy Fluor® 594)
Aperçu rapide pour ADRA2A anticorps (AA 385-450) (AbBy Fluor® 594) (ABIN2809510)
Antigène
Voir toutes ADRA2A AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 385-450
-
Fonction
- ADRA2 Polyclonal Antibody, AbBy Fluor-594 Conjugated
-
Réactivité croisée
- Rat
-
Homologie
- Human,Mouse,Cow,Pig,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human ADRA2
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))
-
Autre désignation
- ADRA2
-
Sujet
-
Synonyms: ADRA2, ADRAR, ZNF32, ADRA2R, ALPHA2AAR, Alpha-2A adrenergic receptor, Alpha-2 adrenergic receptor subtype C1, Alpha-2A adrenoreceptor, Alpha-2A adrenoceptor, Alpha-2AAR, ADRA2A
Background: Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol.
-
ID gène
- 150
-
UniProt
- P08913
-
Pathways
- EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity
Antigène
-